FDA Inspection 1264863 — Catalent Pharma Solutions, LLC

Catalent Pharma Solutions, LLC — FEI 1000122400

The FDA completed an inspection of Catalent Pharma Solutions, LLC on April 22, 2025 in Winchester, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 22, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Winchester, KY (United States)

Citations

IDCFRDescription
121521 CFR 211.67(b)Written procedures not established/followed
202721 CFR 211.192Investigations of discrepancies, failures